Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-01
DOI
10.1002/cpt.2029
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cross-site and cross-platform variability of automated patch clamp assessments of drug effects on human cardiac currents in recombinant cells
- (2020) James Kramer et al. Scientific Reports
- Real estate diagrams: A tool to quickly assess the utility of a new predictive technology
- (2019) James C. Felli et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Exposure-response analysis of drug-induced QT interval prolongation in telemetered monkeys for translational prediction to human
- (2019) Ryuichi Komatsu et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy
- (2019) Zhihua Li et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Improving prediction of torsadogenic risk in the CiPA in silico model by appropriately accounting for clinical exposure
- (2019) Derek J. Leishman JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Can non-clinical repolarization assays predict the results of clinical thorough QT studies? Results from a research consortium
- (2018) Eunjung Park et al. BRITISH JOURNAL OF PHARMACOLOGY
- CiPA challenges and opportunities from a non-clinical, clinical and regulatory perspectives. An overview of the safety pharmacology scientific discussion
- (2018) Rob Wallis et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative
- (2018) Zhihua Li et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
- (2018) Ksenia Blinova et al. Cell Reports
- Scientific white paper on concentration-QTc modeling
- (2017) Christine Garnett et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- An Analysis of the Relationship Between Preclinical and Clinical QT Interval-Related Data
- (2017) Christopher E. Pollard et al. TOXICOLOGICAL SCIENCES
- Proarrhythmia liability assessment and the comprehensive in vitro Proarrhythmia Assay (CiPA): An industry survey on current practice
- (2017) Simon Authier et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Evolution of strategies to improve preclinical cardiac safety testing
- (2016) Gary Gintant et al. NATURE REVIEWS DRUG DISCOVERY
- Shortening of the electromechanical window in the ketamine/xylazine-anesthetized guinea pig model to assess pro-arrhythmic risk in early drug development
- (2016) P. Morissette et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Evaluation of drug-induced QT interval prolongation in animal and human studies: a literature review of concordance
- (2015) Hugo M Vargas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Results From the IQ-CSRC Prospective Study Support Replacement of the Thorough QT Study by QT Assessment in the Early Clinical Phase
- (2015) B Darpo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- QT-prolonging effects of monoclonal antibody drugs in humans: a systematic review of two literature and a public adverse event database
- (2015) Torquil Jackson et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- The Concordance between Nonclinical and Phase I Clinical Cardiovascular Assessment from a Cross-Company Data Sharing Initiative
- (2014) Lorna Ewart et al. TOXICOLOGICAL SCIENCES
- Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium
- (2013) Philip T. Sager et al. AMERICAN HEART JOURNAL
- Detection of QTc interval prolongation using jacket telemetry in conscious non-human primates: comparison with implanted telemetry
- (2013) K Derakhchan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dealing with Global Safety Issues
- (2013) Norman Stockbridge et al. DRUG SAFETY
- MICE Models: Superior to the HERG Model in Predicting Torsade de Pointes
- (2013) James Kramer et al. Scientific Reports
- Translational pharmacokinetic–pharmacodynamic modeling of QTc effects in dog and human
- (2013) Joanna Parkinson et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- A history of the role of the hERG channel in cardiac risk assessment
- (2013) David Rampe et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Preclinical QT safety assessment: Cross-species comparisons and human translation from an industry consortium
- (2013) Henry Holzgrefe et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- The Cost-Effectiveness of Drug Regulation: The Example of Thorough QT/QTc Studies
- (2011) J C Bouvy et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Best practice in the conduct of key nonclinical cardiovascular assessments in drug development: Current recommendations from the Safety Pharmacology Society
- (2011) D.J. Leishman et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Electrocardiographic assessment for therapeutic proteins—scientific discussion
- (2010) Ignacio Rodriguez et al. AMERICAN HEART JOURNAL
- An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation
- (2010) Gary Gintant PHARMACOLOGY & THERAPEUTICS
- Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37°C: Cisapride versus dofetilide
- (2010) James T. Milnes et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Integrated risk assessment and predictive value to humans of non-clinical repolarization assays
- (2009) Robert M Wallis BRITISH JOURNAL OF PHARMACOLOGY
- Comparison of electrocardiographic analysis for risk of QT interval prolongation using safety pharmacology and toxicological studies
- (2009) B.D. Guth et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Assessment of two external telemetry systems (PhysioJacket™ and JET™) in beagle dogs with telemetry implants
- (2009) Ray W. Chui et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Non-invasive telemetric electrocardiogram assessment in conscious beagle dogs
- (2009) Helen Prior et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- In vitromodels of proarrhythmia
- (2008) C L Lawrence et al. BRITISH JOURNAL OF PHARMACOLOGY
- Key clinical considerations for demonstrating the utility of preclinical models to predict clinical drug-induced torsades de pointes
- (2008) P T Sager BRITISH JOURNAL OF PHARMACOLOGY
- Sensitive and reliable proarrhythmiain vivoanimal models for predicting drug-induced torsades de pointes in patients with remodelled hearts
- (2008) A Sugiyama BRITISH JOURNAL OF PHARMACOLOGY
- Overcoming hERG Affinity in the Discovery of Maraviroc; A CCR5 Antagonist for the Treatment of HIV
- (2008) David Price et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The anaesthetised methoxamine-sensitised rabbit model of torsades de pointes
- (2008) Leif Carlsson PHARMACOLOGY & THERAPEUTICS
- Scientific review and recommendations on preclinical cardiovascular safety evaluation of biologics
- (2008) Hugo M. Vargas et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started